Manuel Terrazas-Aranibar

Manuel Terrazas-Aranibar

Auto-generated profile, based on publicly available information

Manuel Terrazas-Aranibar

National Reference Laboratory for Sexually Transmitted Viruses, National Institute of Health, Lima, Peru

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2026 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
Carlos Augusto YabarCarlos Augusto Yabar
Carlos Augusto Yabar
KVKarolyn Vega-Chozo
Karolyn Vega-Chozo
EMEduardo Miranda-Ulloa
Eduardo Miranda-Ulloa
FPFlor de María Peceros-Pelaez
Flor de María Peceros-Pelaez
MTManuel Terrazas-Aranibar
Manuel Terrazas-Aranibar
NRNancy Rojas-Serrano
Nancy Rojas-Serrano
El estudio tuvo como objetivo identificar las coinfecciones de SARS-CoV-2 con otros virus en pacientes con COVID-19 moderada y grave. Se seleccionaron 98 pacientes de Lima, San Martín y Loreto, a quienes se tomaron muestras de secreción nasofaríngea, sangre y orina analizadas mediante pruebas serológicas y moleculares para detectar HTLV, VIH, hepatitis B, dengue, Chikungunya, Zika y un panel de virus respiratorios (influenza A/B, rinovirus, virus respiratorio sincitial, metaneumovirus y adenovirus). Los resultados mostraron dos casos de coinfección (2/98; 2%): uno con SARS-CoV-2/rinovirus y otro con SARS-CoV-2/HTLV-2. Ambos pacientes presentaron neumonía asociada a COVID-19, pero evolucionaron favorablemente. Se concluye que la frecuencia de coinfección viral en pacientes de establecimientos de salud de la costa y selva peruana con cuadros moderados y graves de COVID-19 fue baja.

29 July 2025 in bioRxiv
Verified
Preprint
Open access
JBJohanna Balbuena-Torres
Johanna Balbuena-Torres
RGRonnie Gavilan-Chavez
Ronnie Gavilan-Chavez
FCFany Cárdenas-Bustamante
Fany Cárdenas-Bustamante
MTManuel Terrazas-Aranibar
Manuel Terrazas-Aranibar
MMMaria Martinez-Gago
Maria Martinez-Gago
CCCésar Cabezas
César Cabezas
Objective: To characterize the molecular epidemiology and genomic diversity of hepatitis B virus (HBV) and hepatitis delta virus (HDV) in Peru using next-generation sequencing (NGS). Materials and Methods: A cross-sectional observational study was conducted using 209 serum/plasma samples from various regions of Peru, stored at the National Institute of Health. Detection of HBV and HDV was performed by PCR and RT-PCR, respectively. Nucleic acids were purified and quantified for library preparation and sequencing using the Illumina platform. Sequencing reads were aligned to reference genomes to determine genotypes, subgenotypes, and clinically relevant mutations. Geneious Prime was used for assembly and phylogenetic analysis, and STATA v.14.0 for statistical analysis. Results: HBV genotype F was the most prevalent (96.1%), with subgenotype F1b being predominant, followed by genotypes H, G, and C. Mutations associated with virulence and immune escape were identified, particularly A1762T/G1764A (66.7%) and A1762T/G1764A + G1896A (45.7%). All HDV sequences corresponded to genotype 3 (HDV-3), which was detected in six regions of the country. Conclusions: The findings confirm the predominant circulation of HBV genotype F and HDV genotype 3 in Peru, with genotypic diversity that may influence clinical outcomes, viral load, and response to treatment. Sustained molecular surveillance programs are recommended in endemic areas to guide control, treatment, and prevention strategies.